UNIGE document Scientific Article
previous document  unige:20067  next document
add to browser collection
Title

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Authors
Ruhstaller, T.
Widmer, L.
Schuller, J. C.
Hess, V.
Mingrone, W.
von Moos, R.
Borner, M.
show hidden authors show all authors [1 - 15]
Published in Annals of Oncology. 2009, vol. 20, no. 9, p. 1522-1528
Abstract BACKGROUND: This multicenter phase II study investigated the efficacy and feasibility of preoperative induction chemotherapy followed by chemoradiation and surgery in patients with esophageal carcinoma. PATIENTS AND METHODS: Patients with locally advanced resectable squamous cell carcinoma or adenocarcinoma of the esophagus received induction chemotherapy with cisplatin 75 mg/m(2) and docetaxel (Taxotere) 75 mg/m(2) on days 1 and 22, followed by radiotherapy of 45 Gy (25 x 1.8 Gy) and concurrent chemotherapy comprising cisplatin 25 mg/m(2) and docetaxel 20 mg/m(2) weekly for 5 weeks, followed by surgery. RESULTS: Sixty-six patients were enrolled at eleven centers and 57 underwent surgery. R0 resection was achieved in 52 patients. Fifteen patients showed complete, 16 patients nearly complete and 26 patients poor pathological remission. Median overall survival was 36.5 months and median event-free survival was 22.8 months. Squamous cell carcinoma and good pathologically documented response were associated with longer survival. Eighty-two percent of all included patients completed neoadjuvant therapy and survived for 30 days after surgery. Dysphagia and mucositis grade 3/4 were infrequent (<9%) during chemoradiation. Five patients (9%) died due to surgical complications. CONCLUSIONS: This neoadjuvant, taxane-containing regimen was efficacious and feasible in patients with locally advanced esophageal cancer in a multicenter, community-based setting and represents a suitable backbone for further investigation.
Keywords AdultAgedAntineoplastic Combined Chemotherapy Protocols/*therapeutic useCarcinoma/mortality/*therapyCisplatin/administration & dosage/adverse effectsCombined Modality TherapyDigestive System Surgical ProceduresEsophageal Neoplasms/mortality/*therapyFemaleHumansKaplan-Meier EstimateMaleMiddle Aged*Neoadjuvant TherapyNeoplasm StagingRadiotherapyTaxoids/administration & dosage/adverse effectsTreatment Outcome
Identifiers
PMID: 19465425
Full text
Structures
Research groups Groupe Roth Arnaud (oncologie) (285)
Amnésie (289)
Citation
(ISO format)
RUHSTALLER, T. et al. Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). In: Annals of Oncology, 2009, vol. 20, n° 9, p. 1522-1528. https://archive-ouverte.unige.ch/unige:20067

201 hits

0 download

Update

Deposited on : 2012-04-23

Export document
Format :
Citation style :